Evidence for the therapeutic potential of ex vivo expanded human endothelial progenitor cells using autologous serum

Circulation Journal

Volumn 74, Issue 5, 2010, Pages 1006-1013

  Shumiya, Takanori ^a   Shibata, Rei ^a   Shimizu, Yuuki ^a   Ishii, Masakazu ^a   Kubota, Ryuji ^a   Shintani, Satoshi ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Autologous serum; Endothelial progenitor cells; Therapeutic angiogenesis

Indexed keywords

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; HINDLIMB; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIMB BLOOD FLOW; LIMB ISCHEMIA; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SERUM; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION;

ANIMALS; CAPILLARIES; CATTLE; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HINDLIMB; HUMANS; ISCHEMIA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; SERUM; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 77951715185     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0584     Document Type: Article

References (29)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
3. Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 1992; 116: 435-439.
4. Weiss MJ, Orkin SH. In vitro differentiation of murine embryonic stem cells: New approaches to old problems. J Clin Invest 1996; 97: 591-595.
5. Nieda M, Nicol A, Denning-Kendall P, Sweetenham J, Bradley B, Hows J. Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol 1997; 98: 775-777.
6. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536.
7. Naruse K, Hamada Y, Nakashima E, Kato K, Mizubayashi R, Kamiya H, et al. Therapeutic neovascularization using cord bloodderived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005; 54: 1823-1828.
8. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
9. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-637.
10. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomized controlled trial. Lancet 2002; 360: 427-435.
11. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II: Cell-based therapies. Circulation 2004; 109: 2692-2697.
12. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial. Circulation 2007; 115: 3165-3172.
13. Tse HF, Siu CW, Zhu SG, Songyan L, Zhang QY, Lai WH, et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 2007; 9: 747-753.
14. Yanagihara K, Terada S, Miki M, Sasaki M, Yamada H. Effect of the silk protein sericin on the production of adenovirus-based genetherapy vectors. Biotechnol Appl Biochem 2006; 45: 59-64.
15. Miura M, Numaguchi Y, Ishii M, Kubota R, Takeuchi T, Imamura A, et al. Differentiation capacity of endothelial progenitor cells correlates with endothelial function in healthy young men. Circ J 2009; 73: 1324-1329.
16. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
17. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-2578.
18. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of angiogenesis. Am J Pathol 1998; 52: 1667-1679.
19. Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006; 114: 2163-2169.
20. Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007; 71: 196-201.
21. Lian F, Xue S, Gu P, Zhu HS. The long-term effect of autologous endothelial progenitor cells from peripheral blood implantation on infarcted myocardial contractile force. J Int Med Res 2008; 36: 40-46.
22. +) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 2003; 22: 344-348.
23. Ishikawa M, Asahara T. Endothelial progenitor cell culture for vascular regeneration. Stem Cells Dev 2004; 13: 344-349.
24. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109: 1615-1622.
25. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
26. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
27. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442-1447.
28. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-1595.
29. Yasu T. Differentiation of endothelial progenitor cells. Circ J 2009; 73: 1199-1200.